+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Chlorpheniramine Maleate Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Dosage Form Coverage, Application Coverage, Distribution Channel Coverage, Geographic Coverage and Company)

  • PDF Icon

    Report

  • 172 Pages
  • December 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5918326
Description Jump to:
The global chlorpheniramine maleate market is set to experience robust growth, driven by factors such as the increasing prevalence of allergic illnesses, broadening applications of chlorphenamine, and rapid advancements in medication delivery methods. According to a recent market forecast, the chlorpheniramine maleate market is projected to grow from US$0.5 billion in 2022 to US$0.74 billion by the end of 2030, with a compound annual growth rate (CAGR) of 5.5% during the period from 2023 to 2030.

Key Growth Determinants

1. Rising Prevalence of Allergic Illnesses: The global prevalence of allergic conditions, including allergic rhinitis, asthma, and food allergies, is on the rise. This surge in allergic disorders, especially in low- and middle-income countries, is a significant driver of the chlorpheniramine maleate market.
2. Broadening Application Range of Chlorphenamine: Chlorpheniramine maleate, a first-generation antihistamine, is widely used to manage symptoms of cold, allergic rhinitis, urticaria, and asthma. Its expanding range of applications, including veterinary use, contributes to market growth.
3. Rapid Developments in Medication Delivery Methods: Ongoing advancements in medication delivery methods, such as transdermal patches and nasal sprays, have improved the ease and efficiency of administering chlorpheniramine maleate. These innovations enhance patient compliance and fuel market expansion.

Major Growth Barriers

1. Potential Side Effects: Chlorpheniramine maleate can cause side effects such as drowsiness, blurred vision, and dry mouth. These adverse effects, along with contraindications for certain populations, hinder market growth.
2. Availability of Substitute Drugs: The presence of alternative antihistamines with enhanced efficacy and fewer side effects, such as loratadine and cetirizine, poses a threat to the chlorpheniramine maleate market.

Regional Frontrunners

1. North America Provides the Largest Playing Ground to Manufacturers: North America dominates the chlorpheniramine maleate market, driven by a focus on personalized treatment, growing allergy prevalence, and the presence of key industry players. The region continues to experience rapid market expansion.
2. Growing Prevalence of Allergies Instrumental in Rapid Market Build-up in Asia Pacific: The Asia Pacific region is witnessing the fastest growth in the chlorpheniramine maleate market, attributed to increasing urbanization, environmental pollution, and a rising number of allergy cases. Large patient populations in countries like India contribute to market expansion.

Leaders in Global Chlorpheniramine Maleate Space

Several prominent companies are vying for market leadership in the competitive chlorpheniramine maleate market. Key players include:

  • Viatris Inc.
  • Alkem Laboratories Ltd.
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Capellon Pharmaceuticals
  • GlaxoSmithKline plc
  • Zydus Lifesciences Limited
  • Novalab Healthcare Pvt. Ltd.
  • Sun Pharmaceutical Industries Limited
  • Bayer AG
  • Cardinal Health, Inc.
  • AstraZeneca PLC
  • BOC Sciences
  • Mylan N.V.
  • UCB, Inc.

Chlorpheniramine Maleate Market is Segmented as Below:

By Dosage Form

  • Tablets
  • Syrup
  • Eye Drops

By Application

  • Allergy
  • Hay Fever (Allergic Rhinitis)
  • Common Cold
  • Watery Eyes
  • Itchy Throat/Skin
  • Anaphylactic Shock
  • Urticaria

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geographic Coverage:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Turkey
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • GCC
  • South Africa
  • Egypt
  • Nigeria
  • Rest of Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Chlorpheniramine Maleate Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Chlorpheniramine Maleate Market Outlook, 2018 - 2030
3.1. Global Chlorpheniramine Maleate Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. Allergy
3.1.1.2. Hay Fever (Allergic Rhinitis)
3.1.1.3. Common Cold
3.1.1.4. Watery Eyes
3.1.1.5. Itchy Throat/Skin
3.1.1.6. Anaphylactic Shock
3.1.1.7. Urticaria
3.2. Global Chlorpheniramine Maleate Market Outlook, by Dosage Form, Value (US$ Bn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Tablets
3.2.1.2. Syrup
3.2.1.3. Eye Drops
3.3. Global Chlorpheniramine Maleate Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. Hospital Pharmacies
3.3.1.2. Retail Pharmacies
3.3.1.3. Online Pharmacies
3.4. Global Chlorpheniramine Maleate Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Chlorpheniramine Maleate Market Outlook, 2018 - 2030
4.1. North America Chlorpheniramine Maleate Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. Allergy
4.1.1.2. Hay Fever (Allergic Rhinitis)
4.1.1.3. Common Cold
4.1.1.4. Watery Eyes
4.1.1.5. Itchy Throat/Skin
4.1.1.6. Anaphylactic Shock
4.1.1.7. Urticaria
4.2. North America Chlorpheniramine Maleate Market Outlook, by Dosage Form, Value (US$ Bn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Tablets
4.2.1.2. Syrup
4.2.1.3. Eye Drops
4.3. North America Chlorpheniramine Maleate Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. Hospital Pharmacies
4.3.1.2. Retail Pharmacies
4.3.1.3. Online Pharmacies
4.3.2. Market Attractiveness Analysis
4.4. North America Chlorpheniramine Maleate Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
4.4.1. Key Highlights
4.4.1.1. U.S. Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
4.4.1.2. U.S. Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
4.4.1.3. U.S. Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
4.4.1.4. Canada Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
4.4.1.5. Canada Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
4.4.1.6. Canada Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Chlorpheniramine Maleate Market Outlook, 2018 - 2030
5.1. Europe Chlorpheniramine Maleate Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Allergy
5.1.1.2. Hay Fever (Allergic Rhinitis)
5.1.1.3. Common Cold
5.1.1.4. Watery Eyes
5.1.1.5. Itchy Throat/Skin
5.1.1.6. Anaphylactic Shock
5.1.1.7. Urticaria
5.2. Europe Chlorpheniramine Maleate Market Outlook, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Tablets
5.2.1.2. Syrup
5.2.1.3. Eye Drops
5.3. Europe Chlorpheniramine Maleate Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. Hospital Pharmacies
5.3.1.2. Retail Pharmacies
5.3.1.3. Online Pharmacies
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Chlorpheniramine Maleate Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
5.4.1. Key Highlights
5.4.1.1. Germany Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
5.4.1.2. Germany Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.4.1.3. Germany Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.4.1.4. U.K. Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
5.4.1.5. U.K. Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.4.1.6. U.K. Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.4.1.7. France Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
5.4.1.8. France Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.4.1.9. France Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.4.1.10. Italy Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
5.4.1.11. Italy Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.4.1.12. Italy Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.4.1.13. Turkey Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
5.4.1.14. Turkey Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.4.1.15. Turkey Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.4.1.16. Russia Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
5.4.1.17. Russia Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.4.1.18. Russia Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.4.1.19. Rest of Europe Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
5.4.1.20. Rest of Europe Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.4.1.21. Rest of Europe Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Chlorpheniramine Maleate Market Outlook, 2018 - 2030
6.1. Asia Pacific Chlorpheniramine Maleate Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Allergy
6.1.1.2. Hay Fever (Allergic Rhinitis)
6.1.1.3. Common Cold
6.1.1.4. Watery Eyes
6.1.1.5. Itchy Throat/Skin
6.1.1.6. Anaphylactic Shock
6.1.1.7. Urticaria
6.2. Asia Pacific Chlorpheniramine Maleate Market Outlook, by Dosage Form, Value (US$ Bn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Tablets
6.2.1.2. Syrup
6.2.1.3. Eye Drops
6.3. Asia Pacific Chlorpheniramine Maleate Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. Hospital Pharmacies
6.3.1.2. Retail Pharmacies
6.3.1.3. Online Pharmacies
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Chlorpheniramine Maleate Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
6.4.1. Key Highlights
6.4.1.1. China Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
6.4.1.2. China Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
6.4.1.3. China Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
6.4.1.4. Japan Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
6.4.1.5. Japan Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
6.4.1.6. Japan Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
6.4.1.7. South Korea Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
6.4.1.8. South Korea Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
6.4.1.9. South Korea Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
6.4.1.10. India Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
6.4.1.11. India Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
6.4.1.12. India Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
6.4.1.13. Southeast Asia Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
6.4.1.14. Southeast Asia Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
6.4.1.15. Southeast Asia Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
6.4.1.16. Rest of Asia Pacific Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
6.4.1.17. Rest of Asia Pacific Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
6.4.1.18. Rest of Asia Pacific Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Chlorpheniramine Maleate Market Outlook, 2018 - 2030
7.1. Latin America Chlorpheniramine Maleate Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Allergy
7.1.1.2. Hay Fever (Allergic Rhinitis)
7.1.1.3. Common Cold
7.1.1.4. Watery Eyes
7.1.1.5. Itchy Throat/Skin
7.1.1.6. Anaphylactic Shock
7.1.1.7. Urticaria
7.2. Latin America Chlorpheniramine Maleate Market Outlook, by Dosage Form, Value (US$ Bn), 2018 - 2030 7.2.1. Key Highlights 7.2.1.1. Tablets
7.2.1.2. Syrup
7.2.1.3. Eye Drops
7.3. Latin America Chlorpheniramine Maleate Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2030 7.3.1. Key Highlights
7.3.1.1. Hospital Pharmacies
7.3.1.2. Retail Pharmacies
7.3.1.3. Online Pharmacies
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Chlorpheniramine Maleate Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
7.4.1. Key Highlights
7.4.1.1. Brazil Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
7.4.1.2. Brazil Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
7.4.1.3. Brazil Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
7.4.1.4. Mexico Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
7.4.1.5. Mexico Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
7.4.1.6. Mexico Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
7.4.1.7. Argentina Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
7.4.1.8. Argentina Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
7.4.1.9. Argentina Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
7.4.1.10. Rest of Latin America Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
7.4.1.11. Rest of Latin America Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
7.4.1.12. Rest of Latin America Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Chlorpheniramine Maleate Market Outlook, 2018 - 2030
8.1. Middle East & Africa Chlorpheniramine Maleate Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Allergy
8.1.1.2. Hay Fever (Allergic Rhinitis)
8.1.1.3. Common Cold
8.1.1.4. Watery Eyes
8.1.1.5. Itchy Throat/Skin
8.1.1.6. Anaphylactic Shock
8.1.1.7. Urticaria
8.2. Middle East & Africa Chlorpheniramine Maleate Market Outlook, by Dosage Form, Value (US$ Bn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Tablets
8.2.1.2. Syrup
8.2.1.3. Eye Drops
8.3. Middle East & Africa Chlorpheniramine Maleate Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. Hospital Pharmacies
8.3.1.2. Retail Pharmacies
8.3.1.3. Online Pharmacies
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Chlorpheniramine Maleate Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
8.4.1. Key Highlights
8.4.1.1. GCC Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
8.4.1.2. GCC Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
8.4.1.3. GCC Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
8.4.1.4. South Africa Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
8.4.1.5. South Africa Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
8.4.1.6. South Africa Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
8.4.1.7. Egypt Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
8.4.1.8. Egypt Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
8.4.1.9. Egypt Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
8.4.1.10. Nigeria Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
8.4.1.11. Nigeria Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
8.4.1.12. Nigeria Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
8.4.1.13. Rest of Middle East & Africa Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
8.4.1.14. Rest of Middle East & Africa Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
8.4.1.15. Rest of Middle East & Africa Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs Application Heatmap
9.2. Company Market Share Analysis, 2022
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Sun Pharmaceutical Industries Limited
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Novalab Healthcare Pvt. Ltd
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Zydus Lifesciences Limited
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. GlaxoSmithKline plc
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Capellon Pharmaceuticals
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Johnson & Johnson
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Merck & Co., Inc.
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Alkem Laboratories Ltd.
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Viatris Inc.
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Bayer AG
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Cardinal Health, Inc.
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. AstraZenca PLC
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. BOC Sciences
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
9.4.14. Mylan N.V.
9.4.14.1. Company Overview
9.4.14.2. Product Portfolio
9.4.14.3. Financial Overview
9.4.14.4. Business Strategies and Development
9.4.15. UCB, Inc.
9.4.15.1. Company Overview
9.4.15.2. Product Portfolio
9.4.15.3. Financial Overview
9.4.15.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Sun Pharmaceutical Industries Limited
  • Novalab Healthcare Pvt. Ltd.
  • Zydus Lifesciences Limited
  • GlaxoSmithKline plc
  • Capellon Pharmaceuticals
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Alkem Laboratories Ltd.
  • Viatris Inc.
  • Bayer AG
  • Cardinal Health, Inc.
  • AstraZeneca PLC
  • BOC Sciences
  • Mylan N.V.
  • UCB, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Chlorpheniramine Maleate Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Chlorpheniramine Maleate Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Chlorpheniramine Maleate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Chlorpheniramine Maleate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 93 Pages
  • Global
From
Chlorpheniramine maleate (CAS 113-92-8) Global Market Research Report 2024 - Product Image

Chlorpheniramine maleate (CAS 113-92-8) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Dextromethorphan - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Dextromethorphan - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
Chronic Cough Global Market Report 2024 - Product Image

Chronic Cough Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.